About
Cannabinoid-based Pharmaceuticals
Lara Pharm Ltd develops pharmaceutical-grade cannabinoids and related technology. By developing a way to mass-produce standardized cannabis-based prescription drugs,Lara Pharmseeks to eliminate the need for medical marijuana. The company has developed an inhaler that delivers a controlled dose of cannabinoids. Lara Pharm was acquired by Israeli Therapix Biosciences Ltd. (TASE: TRPH, formerly NasVax), back in August 2014.
Identity
| Name | Lara Pharm |
|---|---|
| Slug | larapharm |
| Type / kind | startup |
| Crunchbase ID | larapharm |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgJ6Tz_AIDA |
Status
| Status | inactive |
|---|---|
| Status reason | Acquired (Inactive) by SciSparc on Aug 2014 - closed due to acquisition |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Tel Aviv-Yafo |
| HQ address | Derech Menachem Begin 132, Tel Aviv-Yafo, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrug DeliveryMedical DevicesMedical Treatment & Therapeutics
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business models
B2B
Tags
inhalationsleep-disorderscannabispharma-companiesglaucomaepilepsydiabetespain-reliefchemotherapy
Funding
| Total raised | $1.5M |
|---|---|
| Current stage | Acquired |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}